Ischemia modified-albumin as a biomarker of myocardial ischemia : early diagnosis of acute coronary syndrome and cost effectiveness analysis
Ischemia modified-albumin (IMA®) is a useful early cardiac biomarker for the diagnosis of acute coronary syndrome. In this study the diagnostic efficiency and the cost effectiveness of the oxidative stress biomarker (ischemia modified-albumin), myocardial necrosis (high sensitivity cardiac troponin,...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Portsmouth
2016
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.765652 |